Coloplast A/S (OTCMKTS:CLPBY) Announces Quarterly Earnings Results

Coloplast A/S (OTCMKTS:CLPBY) released its quarterly earnings data on Tuesday. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09, Zacks reports. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%.

Coloplast A/S Stock Up 5.1%

Shares of OTCMKTS CLPBY traded up $0.38 during trading hours on Wednesday, hitting $7.76. 155,076 shares of the stock were exchanged, compared to its average volume of 427,691. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $9.70. The firm has a fifty day moving average price of $6.82 and a 200-day moving average price of $6.80. The company has a quick ratio of 0.94, a current ratio of 1.56 and a debt-to-equity ratio of 1.51. The company has a market cap of $17.49 billion, a PE ratio of 40.84, a PEG ratio of 2.40 and a beta of 0.10.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.

Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.